SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-008602
Filing Date
2023-03-20
Accepted
2023-03-20 16:02:46
Documents
76
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nltx-20221231.htm   iXBRL 10-K 1390220
2 EX-10.19 exhibit1019-employmentagre.htm EX-10.19 75403
3 EX-21.1 exhibit211-listofsubsidiar.htm EX-21.1 2493
4 EX-23.1 exhibit231-consentofindepe.htm EX-23.1 2305
5 EX-31.1 exhibit311202210-k.htm EX-31.1 9547
6 EX-32.1 exhibit321202210-k.htm EX-32.1 6108
  Complete submission text file 0001628280-23-008602.txt   6439332

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nltx-20221231.xsd EX-101.SCH 40567
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nltx-20221231_cal.xml EX-101.CAL 75969
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nltx-20221231_def.xml EX-101.DEF 179496
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nltx-20221231_lab.xml EX-101.LAB 590423
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nltx-20221231_pre.xml EX-101.PRE 377908
70 EXTRACTED XBRL INSTANCE DOCUMENT nltx-20221231_htm.xml XML 775130
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36327 | Film No.: 23746396
SIC: 2834 Pharmaceutical Preparations